Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

FDA Compliance Requirements for Non-Invasive Bone Growth Stimulators

$129.99

Stay ahead in medical device compliance with this focused training on the FDA’s new rule reclassifying non-invasive bone growth stimulators to class II status, subject to premarket notification and special controls. This course provides detailed guidance on the latest regulatory standards, actionable compliance steps for manufacturers, and essential documentation for FDA submission. Learn how to address performance testing, labeling, software validation, and mitigate risks—including legal and financial consequences for non-compliance—ensuring your device meets all FDA safety and effectiveness expectations.

In this course you will learn the following:
* Understand the scope and intent of the Final Rule for non-invasive bone growth stimulators.
* Identify the key regulatory requirements and classification details.
* Implement the necessary compliance measures, including performance testing, labeling, and risk mitigation.
* Recognize the legal and financial consequences of non-compliance.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Why This Course is Important
Manufacturers and stakeholders risk regulatory delays, market access loss, and costly enforcement actions if they are unaware of the new FDA requirements and special controls for non-invasive bone growth stimulators.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Physical Medicine Devices; Reclassification of Non-Invasive Bone Growth Stimulators.

Key regulatory references include:

Course SKU
FR-26-1869-1